Article
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.
Journal of hepatology - 1 Jun 2011
Xu Chun-Fang, Reck Brian H, Goodman Vicki L, Xue Zhengyu, Huang Lingkang, Barnes Michael R, Koshy Beena, Spraggs Colin F, Mooser Vincent E, Cardon Lon R, Pandite Lini N
Abstract excerpt
BACKGROUND & AIMS: Pazopanib has demonstrated clinical benefit in patients with advanced renal cell carcinoma (RCC) and is generally well tolerated. However, transaminase elevations have commonly been observed. This 2-stage study sought to identify genetic determinants of alanine transaminase (AL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
